Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-04-14
2011-10-25
Andres, Janet L. (Department: 1622)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
08044208
ABSTRACT:
The present invention is directed to a compound of formula I:or any stereoisomeric form of the compound of the formula I or a mixture of these forms in any ratio or a physiologically acceptable salt of the compound of the formula I which inhibit the enzyme TAFIa (activated thrombin-activatable fibrinolysis inhibitor), and to a process for their preparation and to their use to treat described diseases where the substituents are as described in the specification.
REFERENCES:
patent: WO 02/14285 (2002-02-01), None
patent: WO 03/013526 (2003-02-01), None
patent: WO 03/061653 (2003-07-01), None
Heitsch Holger
Kallus Christopher
Wehner Volkmar
Andres Janet L.
Covington Raymond
Farquharson-Torres Serena
Sanofi-Aventis
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Imidazole derivatives as inhibitors of TAFIa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole derivatives as inhibitors of TAFIa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives as inhibitors of TAFIa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4289020